India Pharma Outlook Team | Tuesday, 29 October 2024
The AI-powered smart haemodialysis machine aims to increase access to renal care and reduce costs by up to 75%, bringing the price down to approximately Rs 2 lakh. Nephro Care India Limited (NCIL) is working with the National Institute of Technology in Silchar to create a prototype of an AI-enabled Smart Haemodialysis Machine that can be monitored remotely.
"The company, in collaboration with National Institute of Technology, Silchar, is developing the prototype with a grant from the Department of Science and Technology and Biotechnology, West Bengal and it is expected to be ready over the next 7-8 months," Dr Pratim Sengupta, Founder and MD & CEO of Nephro Care said.
He stated that once the local machine is created, it will lower the cost from the current Rs 7.5-8 lakh to Rs 2 lakh, a reduction of 70-75 per cent. Saying that most haemodialysis machines in India are currently imported, Sengupta pointed out that device manufacturing locally could lower costs, thus making treatment more affordable for patients with advanced renal failure and supporting the make in India initiative.
The prototype will allow for remote monitoring of dialysis machines, increasing accessibility of treatment in rural and semi-urban areas and closing the gap. According to government calculations, approximately 220,000 individuals in India are diagnosed with end-stage renal disease (ESRD) each year, resulting in a need for an extra 34 million dialysis sessions annually.